Taysha Gene Therapies, Inc. TSHA Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s total operating expenses?
- Taysha Gene Therapies, Inc. (TSHA) reported total operating expenses of $43.49M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s total operating expenses changed year-over-year?
- Taysha Gene Therapies, Inc.'s total operating expenses increased by 83.3% year-over-year, from $23.72M to $43.49M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s total operating expenses has grown at a -8.7% compound annual growth rate (CAGR), from $173.27M to $120.27M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.